Jonathon Unwin
Stock Analyst at Barclays
(0.33)
# 4,500
Out of 5,074 analysts
68
Total ratings
31.4%
Success rate
-11.8%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: VIMIAN Vimian Group AB (publ) | Reiterated: Sell | kr 29.00 | kr 40.05 | -27.59% | 15 | Oct 23, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €27.00 | €35.10 | -23.08% | 12 | Oct 16, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 182p | 211p | -13.91% | 10 | Sep 28, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Reiterated: Buy | CHF 480.00 | CHF 387.40 | +23.90% | 9 | Sep 24, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €16.00 → €27.00 | €24.50 | +10.20% | 13 | Aug 18, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Sell | €17.00 → €25.00 | €32.00 | -21.88% | 9 | Jul 29, 2026 |
Vimian Group AB (publ)
Oct 23, 2026
Reiterated: Sell
Price Target: kr 29.00
Current: kr 40.05
Upside: -27.59%
Carl Zeiss Meditec AG
Oct 16, 2026
Reiterated: Hold
Price Target: €27.00
Current: €35.10
Upside: -23.08%
Oxford Nanopore Technologies plc
Sep 28, 2026
Reiterated: Buy
Price Target: 182p
Current: 211p
Upside: -13.91%
Ypsomed Holding AG
Sep 24, 2026
Reiterated: Buy
Price Target: CHF 480.00
Current: CHF 387.40
Upside: +23.90%
SCHOTT Pharma AG & Co. KGaA
Aug 18, 2026
Upgraded: Buy
Price Target: €16.00 → €27.00
Current: €24.50
Upside: +10.20%
Gerresheimer AG
Jul 29, 2026
Reiterated: Sell
Price Target: €17.00 → €25.00
Current: €32.00
Upside: -21.88%